Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs

Biomaterials

Volumn 33, Issue 27, 2012, Pages 6542-6550

  Park, Ji Hwan ^a   Kim, Hyun Ah ^a   Park, Jin Hyeong ^a   Lee, Minhyung ^a  

^a Hanyang University   (South Korea)

Author keywords

Cell viability; DNA; Gene expression; Gene transfer; Inflammation

Indexed keywords

ACUTE LUNG INJURY; AMPHIPHILICS; ANTI-INFLAMMATORIES; ANTITUMOR EFFECT; CELL VIABILITY; CURCUMIN; EVAPORATION METHOD; GEL-RETARDATION ASSAY; IN-VITRO; IN-VIVO; INFLAMMATION; INTRATRACHEAL INSTILLATION; INTRAVENOUS INJECTIONS; LIPOFECTAMINE; LIPOPOLYSACCHARIDES; LIVER TOXICITY; LUNG TISSUE; MACROPHAGE CELLS; MOUSE LUNG; MOUSE MODELS; NATURAL PRODUCTS; OIL-IN-WATER (O/W) EMULSION; PEPTIDE CARRIER; PLASMID DNA; PLASMID DNA (PDNA); POLY-L-LYSINE; POLYETHYLENIMINES; STABLE COMPLEXES; TRANSFECTION EFFICIENCY;

AMINO ACIDS; BIOLOGICAL ORGANS; BIOMOLECULES; DNA; GENE EXPRESSION; GENE TRANSFER; LIPOSOMES; MAMMALS; PEPTIDES; TISSUE;

EFFICIENCY;

AMPHOPHILE; ARGININE DERIVATIVE; CURCUMIN; HEPARIN; LEUCINE; LIPOFECTAMINE; LIPOPOLYSACCHARIDE; NATURAL PRODUCT; OIL; PEI25K; PEPTIDE DERIVATIVE; PLASMID DNA; POLYETHYLENEIMINE; POLYLYSINE; R7L1 PEPTIDE; SOLVENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMULSION; EVAPORATION; GENETIC TRANSFECTION; IN VIVO STUDY; LIVER TOXICITY; LUNG PARENCHYMA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACUTE LUNG INJURY; ANIMALS; CURCUMIN; DEOXYRIBONUCLEASE I; DNA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; LIVER; LUNG; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; NUCLEASE PROTECTION ASSAYS; PEPTIDES; PLASMIDS; SURFACE-ACTIVE AGENTS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863560200     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.046     Document Type: Article

References (32)

1. Han S., Mahato R.I., Sung Y.K., Kim S.W. Development of biomaterials for gene therapy. Mol Ther 2000, 2:302-317.
2. Niidome T., Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002, 9:1647-1652.
3. Pun S.H., Davis M.E. Development of a nonviral gene delivery vehicle for systemic application. Bioconjug Chem 2002, 13:630-639.
4. Kang H.C., Lee M., Bae Y.H. Polymeric gene carriers. Crit Rev Eukaryot Gene Expr 2005, 15:317-342.
5. Lavigne M.D., Gorecki D.C. Emerging vectors and targeting methods for nonviral gene therapy. Expert Opin Emerg Drugs 2006, 11:541-557.
6. Goncalves M.A., de Vries A.A. Adenovirus: from foe to friend. Rev Med Virol 2006, 16:167-186.
7. Wang Y., Gao S., Ye W.H., Yoon H.S., Yang Y.Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 2006, 5:791-796.
8. Zhu C., Jung S., Luo S., Meng F., Zhu X., Park T.G., et al. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials 2009, 31:2408-2416.
9. Park J.H., Kim H.A., Cho S.H., Lee M. Characterization of hydrophobic anti-cancer drug-loaded amphiphilic peptides as a gene carrier. J Cell Biochem 2012, 113:1645-1653.
10. Lee J., Hyun H., Kim J., Ryu J.H., Kim H.A., Park J.H., et al. Dexamethasone-loaded peptide micelles for delivery of the heme oxygenase-1 gene to ischemic brain. J Control Release 2012, 158:131-138.
11. Hyun H., Lee J., Hwang do W., Kim S., Hyun D.K., Choi J.S., et al. Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone. Biomaterials 2011, 32:306-315.
12. Duvoix A., Blasius R., Delhalle S., Schnekenburger M., Morceau F., Henry E., et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005, 223:181-190.
13. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 2008, 267:133-164.
14. Anand P., Thomas S.G., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Sung B., et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008, 76:1590-1611.
15. Jurenka J.S. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 2009, 14:141-153.
16. Wongcharoen W., Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol 2009, 133:145-151.
17. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009, 41:40-59.
18. Olszanecki R., Gebska A., Korbut R. The role of haem oxygenase-1 in the decrease of endothelial intercellular adhesion molecule-1 expression by curcumin. Basic Clin Pharmacol Toxicol 2007, 101:411-415.
19. Schaffer M., Schaffer P.M., Zidan J., Bar Sela G. Curcuma as a functional food in the control of cancer and inflammation. Curr Opin Clin Nutr Metab Care 2011, 14:588-597.
20. Singh S., Aggarwal B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 1995, 270:24995-25000.
21. Kim H., Kim H.A., Bae Y.M., Choi J.S., Lee M. Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes. J Gene Med 2009, 11:515-522.
22. Lee M., Nah J.W., Kwon Y., Koh J.J., Ko K.S., Kim S.W. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm Res 2001, 18:427-431.
23. Ryu D.W., Kim H.A., Song H., Kim S., Lee M. Amphiphilic peptides with arginines and valines for the delivery of plasmid DNA. J Cell Biochem 2011, 112:1458-1466.
24. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., Demeneix B.A. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 1996, 7:1947-1954.
25. Lemkine G.F., Goula D., Becker N., Paleari L., Levi G., Demeneix B.A. Optimisation of polyethylenimine-based gene delivery to mouse brain. J Drug Target 1999, 7:305-312.
26. Suzuki M., Matsuse T., Isigatsubo Y. Gene therapy for lung diseases: development in the vector biology and novel concepts for gene therapy applications. Curr Mol Med 2001, 1:67-79.
27. McCarter S.D., Mei S.H., Lai P.F., Zhang Q.W., Parker C.H., Suen R.S., et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 2007, 175:1014-1026.
28. Mei S.H., McCarter S.D., Deng Y., Parker C.H., Liles W.C., Stewart D.J. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007, 4:e269.
29. Lomas-Neira J., Chung C.S., Ayala A. RNA interference as a potential therapeutic treatment for inflammation associated lung injury. Int J Clin Exp Med 2008, 1:154-160.
30. Kim H.A., Park J.H., Lee S., Choi J.S., Rhim T., Lee M. Combined delivery of dexamethasone and plasmid DNA in an animal model of LPS-induced acute lung injury. J Control Release 2011, 156:60-69.
31. Matsuda N., Yamamoto S., Takano K., Kageyama S., Kurobe Y., Yoshihara Y., et al. Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis. Am J Respir Crit Care Med 2009, 179:806-815.
32. Won Y.W., Kim H.A., Lee M., Kim Y.H. Reducible Poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection. Mol Ther 2010, 18:734-742.